Sort
82,697 grants matching “vaccine development”
Synthetic Vaccine Against Human Pathogenic Bacteria
$703,608Vince Pozsgay · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Elicitation of broad immunity using VLPs with consensus envs
$703,575Ted M Ross · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · AI
B cells and humoral immunity in tuberculosis
$703,554John R. Chan · Albert Einstein College Of Medicine · R01 · FY2014 · AI
Merkel cell polyomavirus HLA class I epitopes for generating therapeutic T cell-based cancer immunotherapy
$703,510Derin B Keskin · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Accelerating Malaria Vaccines with a Custom Preclinical Humanized Mouse Model Platform
$703,481Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2023 · AI
Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity
$703,392Pardis Christine Sabeti · Broad Institute, Inc. · U19 · FY2020 · AI
The role of enteric pathogens and antimicrobial resistance in driving clinical and nutritional deterioration, and azithromycin's potential effect, among children discharged from hospital in Kenya
$703,337Patricia Pavlinac · University Of Washington · R01 · FY2024 · AI
MAb Passive Vaccination against Acinetobacter baumannii
$703,322Brad J Spellberg · University Of Southern California · R01 · FY2019 · AI
Adaptation and Implementation of an Evidence-Based Patient Navigation Intervention for Adolescent and Young Adult Cancer Survivors
$703,321Erin Elizabeth Hahn · Kaiser Foundation Research Institute · UG3 · FY2025 · CA
Design of fusion inhibitors to block measles host-to-host infection
$703,309Matteo Porotto · Columbia University Health Sciences · R01 · FY2024 · AI
Acquisition of HCMV from breast milk-correlates of protection
$703,280Suresh B Boppana · University Of Alabama At Birmingham · R01 · FY2015 · AI
Targeting 5' leader-encoded defective ribosomal products for HIV T cell vaccines
$703,267George M Shaw · University Of Pennsylvania · R01 · FY2020 · AI
Natural History of Pre-Diabetic Autoimmunity (DAISY)
$703,201Marian J. Rewers · University Of Colorado Denver · R01 · FY2021 · DK
ADOLESCENT MEDICINE TRIALS UNIT (AMTU)
$703,131Mount Sinai School Of Medicine Of Nyu · U01 · FY2002 · HD
Optimization of rAAV Vector Strategies for HIV
$703,121Research Inst Nationwide Children'S Hosp · P01 · FY2004 · AI
EpiMoRPH: A simulation environment for generating spatially-refined intervention strategies for the control of infectious disease
$703,090Joseph Mihaljevic · Northern Arizona University · R01 · FY2023 · AI
Structure-guided vaccine design of HCV E1E2 to induce broadly neutralizing antibodies (bNAbs)
$703,062Steven Foung · Stanford University · U19 · FY2021 · AI
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
$703,025Mark Yarchoan · Johns Hopkins University · R01 · FY2023 · CA
TRIALS OF VITAMINS IN HIV PROGRESSION AND TRANSMISSION
$703,015Harvard University (Sch Of Public Hlth) · R01 · FY2000 · HD
Community-Centered Interventions for Improved Vaccine Uptake for COVID (CIVIC)
$703,005Erica E Marsh · University Of Michigan At Ann Arbor · R01 · FY2021 · MD
Network-based study design, statistical, and modeling solutions for HIV among populations that use illicit substances: Informing interventions and policy in real-world settings using existing data
$702,925Ashley Lynn Buchanan · University Of Rhode Island · R01 · FY2025 · DA
A Community Mycobacterial Systems Resource
$702,919Keith M Derbyshire · Wadsworth Center · R01 · FY2014 · AI
Skin Vaccination Against Influenza in the Young And Aged
$702,916Richard W Compans · Emory University · R01 · FY2015 · AI
Multivalent Toxoid Vaccine for recurrent Staphylococccus aureus disease
$702,876M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2022 · AI
Developmental Research Program
$702,804W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2013 · AI